This report provides exclusive insights into the COVID-19 impact on the Multiple Sclerosis Market. The detailed analysis provides information about the impact of the outbreak on the demand and supply conditions, trends and forecasts of the Multiple Sclerosis Market. Moreover, the impact analysis covers the study of the COVID-19 on the supply chain of Multiple Sclerosis Market. The sectoral impact shall provide insights into both short term and long term effects of the pandemic on the related and support industries.
A recent report published by
Infinium Global Research on multiple sclerosis market provides an in-depth
analysis of segments and sub-segments in the global as well as regional
multiple sclerosis market. The study also highlights the impact of drivers,
restraints, and macro indicators on the global and regional multiple sclerosis
market over the short term as well as long term. The report is a comprehensive
presentation of trends, forecast and dollar values of the global multiple
sclerosis market. According to the report, the global multiple sclerosis market
is projected to grow at a healthy CAGR over the forecast period of 2019-2025.
Multiple Sclerosis is an
inflammatory medical condition characterized by neural demyelination which
results in physical and cognitive disability. Companies operating in multiple
sclerosis market are adopting strategies such as a merger, acquisition, and new
product launches that maximize the market share. In 2016, Teva Industries
acquired Actavis Generics. The acquisition enhances the research and
development and complementary skills of both companies.
The increasing research and
development activities in pharmaceutical companies drive the growth of multiple
sclerosis market. The increasing number of cases of multiple sclerosis market
contributes to the growth of the multiple sclerosis market. As per recent
findings from the National Multiple Sclerosis Society, around 2.3 million
people globally are suffering from multiple sclerosis. The advancement in
technology in the field of multiple sclerosis management fuels the growth of
multiple sclerosis market. The increasing government initiatives for
reimbursement propel the growth of multiple sclerosis market. On the other
side, the unaffordable cost of drugs and the side effects of therapeutics in
the treatment of multiple sclerosis hinder the growth of multiple sclerosis
market. Moreover, new innovative product launches and different therapies with
minimum side effects create novel opportunities for the growth of multiple
On the basis of geography, the
global multiple sclerosis market is divided into North America, Asia-Pacific,
Europe, and the Rest of the World. North America is anticipated to have a
premium share in the global multiple sclerosis market. The growing number of
patients suffering from multiple sclerosis in the U.S. contributes to the
growth of the multiple sclerosis market in North America. According to findings
from the National Multiple Sclerosis Society, around 1 million people in the
U.S. are suffering from multiple sclerosis. The Asia-Pacific region is expected
to grow in the global multiple sclerosis market with a healthy CAGR over the
forecast period. The increasing demand for affordable and effective treatment
on multiple sclerosis in the Asia-Pacific region fuels new product launches in
the region stimulating the growth of the Asia-Pacific multiple sclerosis
market. Europe is also showing growth in the global multiple sclerosis market.
The report on the global multiple
sclerosis market covers segments such as treatment modality and application. On
the basis of treatment modality, the sub-markets include injectable agents, and
oral agents. On the basis of application, the sub-markets include hospital, and
The report provides profiles of
the companies in the market such as Pfizer Inc., Teva Pharmaceuticals
Industries Ltd., Merck & Co. Inc., AbbVie Inc., Bayer HealthCare
Pharmaceuticals LLC, Novartis International AG, Sanofi Aventis, Biogen Idec, F.
Hoffmann-La Roche AG, Synthetic Biologics, Inc., and other companies.
The report provides deep insights
into the demand forecasts, market trends, and micro and macro indicators. In
addition, this report provides insights into the factors that are driving and
restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis
given in the report brings an insight into the investment areas that existing
or new market players can consider. The report provides insights into the market
using analytical tools such as Porter's five forces analysis and DRO analysis
of multiple sclerosis market. Moreover, the study highlights current market
trends and provides forecast from 2019-2025. We also have highlighted future
trends in the market that will affect the demand during the forecast period.
Moreover, the competitive analysis given in each regional market brings an
insight into the market share of the leading players.